Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock.
89bio (NASDAQ:ETNB) Price Target Raised to $38.00
(NASDAQ:ETNB – Get Free Report) had its price target boosted by stock analysts at UBS Group from $25.00 to $38.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a ...
The Armenian Reporter3h
Nebius Group (NASDAQ:NBIS) Trading 6.7% Higher – Still a Buy?
Nebius Group N.V. (NASDAQ:NBIS – Get Free Report) shot up 6.7% during trading on Friday . The stock traded as high as $34.59 and last traded at $33.92. 4,652,121 shares were traded during mid-day ...
The Armenian Reporter3h
89bio, Inc. (NASDAQ:ETNB) Receives $30.33 Average Target Price from Brokerages
Shares of 89bio, Inc. (NASDAQ:ETNB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat reports.
Global News14h
Saskatoon Events
An informative and eye-opening information session presented by Pro Bono Students Canada’s Wills Project (PBSC) that will give you the knowledge and understanding of wills, power of attorney ...